You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 4, April 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CSF Somatostatin and Abnormal Response to Dexamethasone Administration in Schizophrenic and Depressed Patients

Allen R. Doran, MD; David R. Rubinow, MD; Alec Roy, MB; David Pickar, MD

Arch Gen Psychiatry. 1986;43(4):365-369.


Abstract

• Low levels of cerebrospinal fluid (CSF) somatostatin and abnormal response to dexamethasone are two neuroendocrine disturbances reported to appear in depression and other neuropsychiatric disorders. We measured the levels of CSF somatostatin in patients with schizophrenia (n = 44) and depression (n=19). In view of in vitro and animal evidence of the ability of somatostatin to inhibit stimulated corticotropin secretion, we also administered the dexamethasone suppression test to a subgroup of the patients with schizophrenia (n =16) and the total depressed group. Lower levels of CSF somatostatin were found in dexamethasone nonsuppressors regardless of diagnosis and were negatively correlated with maximum postdexamethasone cortisol level in the total and depressed patient groups. These data suggest a functional relationship between hypothalamic-pituitary-adrenal axis hyperactivity and reduced CSF somatostatin level.



Author Affiliations

From the Section on Clinical Studies, Clinical Neuroscience Branch (Drs Doran, Roy, and Pickar), and the Biological Psychiatry Branch (Dr Rubinow), National Institute of Mental Health, Washington, DC.


Footnotes

Accepted for publication May 10, 1985.

Reprint requests to Clinical Neuroscience Branch, National Institute of Mental Health, Bldg 10, Room 4N-214, Washington, DC 20205-1000 (Dr Doran).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mental Disorders Among Alcoholics: Relationship to Age of Onset and Cerebrospinal Fluid Neuropeptides
Roy et al.
Arch Gen Psychiatry 1991;48:423-427.
ABSTRACT  

Depression Among Alcoholics: Relationship to Clinical and Cerebrospinal Fluid Variables
Roy et al.
Arch Gen Psychiatry 1991;48:428-432.
ABSTRACT  

Prednisone Effects on Neurochemistry and Behavior: Preliminary Findings
Wolkowitz et al.
Arch Gen Psychiatry 1990;47:963-968.
ABSTRACT  

Pathological Gambling: A Psychobiological Study
Roy et al.
Arch Gen Psychiatry 1988;45:369-373.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.